Consensus on Medical Treatment of Metastatic Breast Cancer Semir BeslijaJacques BonneterreHeinz Zwierzina OriginalPaper Pages: 1 - 7
The Role of Anthracyclines/Anthraquinones in Metastatic Breast Cancer Semir Beslija OriginalPaper Pages: 25 - 32
Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer Christoph C. Zielinski OriginalPaper Pages: 33 - 36
Definition of An Optimal First-line Chemotherapy in Metastatic Breast Cancer Volker Heinemann OriginalPaper Pages: 43 - 48
Chemotherapy for Advanced Breast Cancer – How Long Should it Continue? Martin R StocklerNicholas JC WilckenAlan S Coates OriginalPaper Pages: 49 - 52
Chemotherapy or Endocrine Therapy for Metastatic Breast Cancer? Nicholas WilckenJoanne HornbuckleDavina Ghersi OriginalPaper Pages: 53 - 56
Aromatase Inhibitors as First Line Treatment: Treatment Cascade After Failure of Aromatase Inhibitors Jacques Bonneterre OriginalPaper Pages: 57 - 61
Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer Wolfgang J. KöstlerChristoph C. Zielinski OriginalPaper Pages: 73 - 84
The Role of Erythropoietin in the Supportive Care of Breast Cancer Simon Van Belle OriginalPaper Pages: 95 - 97
Psychosocial Support for Women with Advanced Breast Cancer Pamela J. Goodwin OriginalPaper Pages: 103 - 110
High Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Breast Cancer: Is there a Place? Edward A. Stadtmauer OriginalPaper Pages: 111 - 115
Future Directions in the Treatment of Metastatic Breast Cancer H. ZwierzinaM. GnantCh. Wiltschke OriginalPaper Pages: 117 - 118
Future Directions in the Treatment of Breast Cancer – Cellular Interventions Using Dendritic Cells Michael F.X. GnantPeter C. DubskyChristoph C. Zielinski OriginalPaper Pages: 119 - 123